Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Polyglutamine and neurodegeneration: structural aspects.

Laura Masino1

  • 1Division of Molecular Structure, National Institute for Medical Research, The Ridgeway, London NW7 1AA, UK. lmasino@nimr.mrc.ac.uk

Protein and Peptide Letters
|June 9, 2004
PubMed
Summary

Polyglutamine (polyQ) diseases stem from expanded protein regions, leading to neurodegeneration. Understanding polyQ protein structure is crucial for developing effective treatments for these inherited disorders.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The local mechanostructural properties of protein cargoes regulate nucleocytoplasmic transport.

Nature physics·2026
Same author

An intrinsically disordered region mediates RNA-binding selectivity and cellular activities of LARP6.

Nature communications·2026
Same author

Integrase anchors viral RNA to the HIV-1 capsid interior.

Nature·2026
Same author

RAD51AP1 is a versatile RAD51 modulator.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Author Correction: TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A.

Nature·2024
Same author

Mechanism of single-stranded DNA annealing by RAD52-RPA complex.

Nature·2024

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background:

  • Polyglutamine (polyQ) diseases are a class of inherited neurodegenerative disorders.
  • These diseases are characterized by the presence of expanded polyglutamine regions in specific proteins.
  • Protein misfolding and aggregation are strongly implicated as direct causes of neurodegeneration in these conditions.

Purpose of the Study:

  • To review recent studies on the structural properties of polyQ proteins.
  • To elucidate the molecular basis of polyQ protein aggregation and fiber formation.
  • To highlight the importance of structural information for understanding pathogenesis and designing therapeutic strategies.

Main Methods:

  • Review of existing scientific literature and studies.

Related Experiment Videos

  • Analysis of structural data related to polyQ proteins.
  • Investigation into the mechanisms of protein aggregation and fibril formation.

    • Main Results:

    • Significant progress has been made in understanding the structural characteristics of polyQ proteins over the past decade.
    • Key insights into the molecular processes driving aggregation and the formation of amyloid-like fibers have been gained.
    • The reviewed studies provide a foundation for future research into polyQ disease mechanisms.

    Conclusions:

    • Detailed structural knowledge of polyQ proteins is essential for deciphering the pathogenesis of polyQ diseases.
    • Understanding protein misfolding and aggregation pathways is critical for developing targeted therapeutic interventions.
    • Continued research into polyQ protein structure and aggregation is vital for advancing treatment strategies.